How to recognize late-onset hypogonadism in men with sexual dysfunction

Asian Journal of Andrology

Volumn 14, Issue 2, 2012, Pages 251-259

  Corona, Giovanni ^a,b   Rastrelli, Giulia ^a   Vignozzi, Linda ^a   Mannucci, Edoardo ^a   Maggi, Mario ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b BELLARIA HOSPITAL   (Italy)

Author keywords

late onset hypogonadism (LOH); male hypogonadism; sexual dysfunction; testosterone

Indexed keywords

TESTOSTERONE;

ANDROGEN DEFICIENCY; CLINICAL FEATURE; CRYPTORCHISM; DELAYED PUBERTY; DISEASE CLASSIFICATION; HYPOGONADISM; HYPOPHYSIS DISEASE; LATE ONSET HYPOGONADISM; MALE SEXUAL DYSFUNCTION; MEDICAL HISTORY; METABOLIC PARAMETERS; PREVALENCE; REVIEW; SEXUALITY; STRUCTURED QUESTIONNAIRE; TESTOSTERONE BLOOD LEVEL; TESTOSTERONE SYNTHESIS; WAIST CIRCUMFERENCE;

AGE OF ONSET; AGING; COMORBIDITY; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPOGONADISM; MALE; OLIGOSPERMIA; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; TESTOSTERONE;

EID: 84858046288     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2011.138     Document Type: Review

References (34)

1. Tajar A, Forti G, O'Neill TW, Lee DM, Silman AJ et al. Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. J Clin Endocrinol Metab 2010; 95: 1810-8.
2. Buvat J, Maggi M, Gooren L, Guay AT, Kaufman J et al. Endocrine aspects of male sexual dysfunctions. In: Montorsi F, Basson R, Adaikan G, Becher E, Clayton A, Giuliano G, Khoury S, Sharlip I, editors. Sexual Medicine, Sexual Dysfunctions in Men and Women. Proceedings of the 3rd International Consultation on Sexual Medicine. Paris: Health Publication Ltd; 2010. p681.
3. Morelli A, Corona G, Filippi S, Ambrosini S, Forti G et al. Which patients with sexual dysfunction are suitable for testosterone replacement therapy? J Endocrinol Invest 2007; 30: 880-8. (Pubitemid 351166313)
4. Corona G, Rastrelli G, Forti G, Maggi M. Update in testosterone therapy for men. J Sex Med 2011; 8: 639-54.
5. Wang C, Nieschlag E, Swerdloff R, Behre HM, Hellstrom WJ et al. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol 2008; 159: 507-14.
6. Novak A, Brod M, Elbers J. Andropause and quality of life: findings from patient focus groups and clinical experts. Maturitas 2002; 43: 231-7. (Pubitemid 35435320)
7. EuroQol Group. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199-208.
8. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-83.
9. Shores MM, Matsumoto AM, Sloan KL, Kivlahan DR. Low serum testosterone and mortality in male veterans. Arch Intern Med 2006; 166: 1660-5. (Pubitemid 44232378)
10. Corona G, Monami M, Boddi V, Cameron-Smith M, Fisher AD et al. Low testosterone is associated with an increased risk of MACE lethality in subjects with erectile dysfunction. J Sex Med 2010 (4 Pt 1); 1557-64.
11. Corona G, Rastrelli G, Vignozzi L, Mannucci E, Maggi M. Testosterone, cardiovascular disease and the metabolic syndrome. Best Pract Res Clin Endocrinol Metab 2011; 25: 337-53.
12. Burris AS, Banks SM, Carter CS, Davidson JM, Sherins RJ. A long-term, prospective study of the physiologic and behavioral effects of hormone replacement in untreated hypogonadal men. J Androl 1992; 13: 297-304.
13. Corona G, Ricca V, Bandini E, Mannucci E, Petrone L et al. Association between psychiatric symptoms and erectile dysfunction. J Sex Med 2008; 5: 458-68. (Pubitemid 351167754)
14. Finkelstein JS, Klibanski A, Neer RM, Greenspan SL, Rosenthal DI et al. Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Med 1987; 106: 354-61. (Pubitemid 17029484)
15. Greenspan SL, Neer RM, Ridgway EC, Klibanski A. Osteoporosis in men with hyperprolactinemic hypogonadism. Ann Intern Med 1986; 104: 777-82. (Pubitemid 16115040)
16. Stepan JJ, Lachman M, Zverina J, Pacovsky V, Baylink DJ. Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. J Clin Endocrinol Metab 1989; 69: 523-7. (Pubitemid 19221221)
17. Maggi M, Schulman C, Quinton R, Langham S, Uhl-Hochgraeber K. The burden of testosterone deficiency syndrome in adult men: economic and quality-of-life impact. J Sex Med 2007; 4: 1056-69. (Pubitemid 47079639)
18. Wu FC, Tajar A, Beynon JM, Pye SR, Silman AJ et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 2010; 363: 123-35.
19. Petak SM, Nankin HR, Spark RF, Swerdloff RS, Rodriguez-Rigau LJ; American Association of Clinical Endocrinologists. American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients-2002 update. Endocr Pract 2002; 8: 440-56.
20. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010; 95: 2536-59.
21. Crown S, Crisp AH. A short clinical diagnostic self-rating scale for psychoneurotic patients. The Middlesex Hospital Questionnaire (M.H.Q.). Br J Psychiatry 1966; 112: 917-23.
22. Morley JE, Charlton E, Patrick P, Kaiser FE, Cadeau P et al. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism 2000; 49: 1239-42.
23. Heinemann LA, Saad F, Heinemann K, Thai DM. Can results of the Aging Males' Symptoms (AMS) scale predict those of screening scales for androgen deficiency? Aging Male 2004; 7: 211-8. (Pubitemid 39315125)
24. Smith KW, Feldman HA, McKinlay JB. Construction and field validation of a selfadministered screener for testosterone deficiency (hypogonadism) in ageing men Clin Endocrinol (Oxf) 2000; 53: 703-11. (Pubitemid 32096681)
25. Rosen RC, Araujo AB, Connor MK, Gerstenberger EP, Morgentaler A et al. The NERI Hypogonadism Screener: psychometric validation in male patients and controls. Clin Endocrinol 2011; 74: 248-56.
26. Tancredi A, Reginster JY, Schleich F, Pire G, Maassen P et al. Interest of the androgen deficiency in aging males (ADAM) questionnaire for the identification of hypogonadism in elderly community-dwelling male volunteers. Eur J Endocrinol 2004; 151: 355-60. (Pubitemid 39307323)
27. Morley JE, Perry HM 3rd, Kevorkian RT, Patrick P. Comparison of screening questionnaires for the diagnosis of hypogonadism. Maturitas 2006; 53: 424-9.
28. Chu LW, Tam S, Kung AW, Lam TP, Lee A et al. A short version of the ADAM Questionnaire for androgen deficiency in Chinese men. Gerontol A Biol Sci Med Sci 2008; 63: 426-31. (Pubitemid 351738425)
29. Blümel JE, Chedraui P, Gili SA, Navarro A, Valenzuela K et al. Is the Androgen Deficiency of Aging Men (ADAM) questionnaire useful for the screening of partial androgenic deficiency of aging men? Maturitas 2009; 63: 365-8.
30. Martínez-Jabaloyas JM, Queipo-Zaragozá A, Rodríguez-Navarro R, Queipo-Zaragozá JA, Gil-Salom M et al. Relationship between the Saint Louis University ADAM questionnaire and sexual hormonal levels in a male outpatient population over 50 years of age. Eur Urol 2007; 52: 1760-7. (Pubitemid 350052405)
31. Emmelot-Vonk MH, Verhaar HJ, Nakhai-Pour HR, Grobbee DE, van der Schouw YT. Low testosterone concentrations and the symptoms of testosterone deficiency according to the Androgen Deficiency in Ageing Males (ADAM) and Ageing Males' Symptoms rating scale (AMS) questionnaires. Clin Endocrinol (Oxf) 2011; 74: 488-94.
32. Corona G, Jannini EA, Maggi M. Inventories for male and female sexual dysfunctions. Int J Impot Res 2006; 18: 236-50.
33. Fairburn CG, Peveler RC, Davies B, Mann JI, Mayou RA. Eating disorders in young adults with insulin dependent diabetes mellitus: a controlled study. BMJ 1991; 303: 17-20.
34. Corona G, Mannucci E, Petrone L, Balercia G, Fisher AD et al. ANDROTEST: a structured interview for the screening of hypogonadism in patients with sexual dysfunction. J Sex Med 2006; 3: 706-15.